```html

Uncomplicated Genital Herpes – A Comprehensive Guide

Overview

Genital herpes is a common sexually transmitted infection (STI) caused primarily by herpes simplex virus type 2 (HSV‑2), and less often by HSV‑1 (the virus that also causes cold sores). When the infection presents with typical lesions but no systemic or severe complications, it is termed **uncomplicated genital herpes**.

• Who it affects: Both men and women can acquire genital herpes. The highest incidence is in sexually active individuals aged 15‑39 years, though the virus can be acquired at any age.
• Prevalence: According to the World Health Organization (WHO), an estimated 417 million people worldwide are living with HSV‑2 infection. In the United States, the CDC reports that about 12% of people aged 14‑49 have HSV‑2 antibodies, indicating past or current infection.
• Why “uncomplicated”? Most infections are limited to local genital lesions, last 7‑10 days, and resolve without scarring or systemic disease. This guide focuses on that typical presentation, not on rare severe manifestations such as disseminated infection, meningitis, or neonatal herpes.

Symptoms

The clinical picture can be subtle, especially during a first episode. Symptoms usually appear 2‑12 days after exposure.

Prodrome (early warning signs)

• Tingling, itching, or burning sensation in the genital or buttock area
• General feeling of illness (low‑grade fever, muscle aches)
• Swollen, tender lymph nodes in the groin

Primary lesions

• Small, fluid‑filled blisters (vesicles) that may appear singly or in clusters on the vulva, penis, perineum, inner thighs, or anal region
• Blisters break open, forming painful shallow ulcers that crust over in 5‑7 days
• Lesions are usually painful, not painless
• Lesion duration: 7‑10 days for the first outbreak; recurrences are typically milder and shorter (3‑5 days)

Other possible manifestations

• Urethritis (painful urination) in men
• Vaginal discharge or dysuria in women
• Fever, headache, or malaise (more common with primary infection)

Asymptomatic shedding

Even when no lesions are visible, HSV can be shed from the genital skin and be transmissible. Studies estimate that about 10‑20% of days may involve viral shedding in infected individuals.

Causes and Risk Factors

Virology

HSV is a DNA virus that establishes lifelong latency in sensory ganglia (typically the sacral ganglia for genital infection). Reactivation triggers recurrent lesions.

Transmission

• Sexual contact (vaginal, anal, oral) with an infected partner
• Skin‑to‑skin contact with an active lesion or area of viral shedding
• Mother‑to‑child transmission during childbirth (not covered in “uncomplicated” adult guide)

Risk factors

• Having multiple sexual partners or a partner with HSV
• Inconsistent condom use (condoms reduce risk by ≈30‑50% but do not eliminate it because lesions can occur on uncovered skin)
• History of other STIs (e.g., chlamydia, gonorrhea) which can cause mucosal inflammation
• Weakened immune system (HIV infection, organ transplant, corticosteroid use)
• Female gender – biologically larger mucosal surface area in the genital tract may increase acquisition risk

Diagnosis

Accurate diagnosis helps guide treatment and counseling.

Clinical evaluation

• Visual inspection of lesions by a clinician
• History taking (date of exposure, prior outbreaks, prodromal symptoms)

Laboratory tests

• Polymerase chain reaction (PCR) swab – most sensitive; detects viral DNA from lesion fluid
• Viral culture – less sensitive than PCR, useful if PCR not available
• Serologic testing (HSV‑1 & HSV‑2 IgG antibodies) – indicates past exposure; not useful for acute diagnosis but helpful for counseling

When to test

• First outbreak with atypical lesions
• Recurrent lesions when the diagnosis is uncertain
• Pregnant women with a history of genital herpes (to determine type and need for antiviral suppressive therapy)

Treatment Options

While there is no cure, antiviral therapy shortens outbreaks, reduces symptom severity, and lowers transmission risk.

Antiviral medications

Medication	Typical Dose (adult)	Duration	Notes
Acyclovir	400 mg orally 5×/day	7–10 days (primary) / 3 days (recurrence)	Cheapest; may cause GI upset
Valacyclovir	1 g orally 2×/day	7–10 days (primary) / 1 day (recurrence)	Higher bioavailability, less frequent dosing
Famciclovir	250 mg orally 3×/day	7–10 days (primary) / 1 day (recurrence)	Alternative for those who cannot tolerate other agents

Suppressive therapy

For individuals with ≥4 outbreaks per year, daily suppressive antiviral (e.g., valacyclovir 500 mg once daily) reduces recurrence frequency by ~70% and transmission risk by ~50% (CDC, 2020).

Lifestyle and supportive care

• Keep affected area clean and dry; gentle washing with mild soap
• Avoid friction (tight clothing, vigorous intercourse) until lesions heal
• Over‑the‑counter analgesics (ibuprofen, acetaminophen) for pain
• Cool compresses or sitz baths can soothe itching

Living with Uncomplicated Genital Herpes

Communication

• Inform current and future sexual partners; honest disclosure is key to trust and prevention.
• Consider counseling or support groups (e.g., American Sexual Health Association resources).

Self‑monitoring

• Track outbreaks in a diary (date, prodrome, severity) to identify triggers.
• Common triggers: stress, fatigue, menstrual cycle, ultraviolet exposure (for HSV‑1 genital infection).

Sexual activity

• Avoid intercourse during an active outbreak.
• When lesions are healed, condom use still reduces—but does not eliminate—risk.
• Consider antiviral suppressive therapy if having frequent recurrences.

Psychological well‑being

Feeling embarrassed or anxious is normal. Cognitive‑behavioral therapy (CBT) and patient education have been shown to improve quality of life (Cleveland Clinic, 2021).

Prevention

• Consistent condom use – reduces risk by ~30%.
• Limiting number of sexual partners and ensuring partners are tested.
• Suppressive antiviral therapy for infected individuals with frequent outbreaks.
• Avoid sexual contact during prodrome or active lesions.
• Regular STI screening – annual testing for sexually active adults per CDC guidelines.

Complications

Although most cases are uncomplicated, untreated or severe infections can lead to:

• Erosive genital dermatitis – chronic ulceration and scarring.
• Psychosexual dysfunction – anxiety, depression, or reduced libido.
• Increased susceptibility to other STIs, including HIV, due to disrupted mucosal barriers.
• Rare systemic spread – meningitis or encephalitis (more common with HSV‑1); requires emergency care.

Prompt antiviral therapy markedly reduces the risk of these complications (Mayo Clinic, 2022).

When to Seek Emergency Care

Key Take‑aways

• Genital herpes is common, usually caused by HSV‑2, and most infections are uncomplicated.
• Typical symptoms include a prodrome followed by painful vesicles that break into ulcers.
• Diagnosis is clinical plus PCR or culture; serology helps with counseling.
• Antiviral therapy (acyclovir, valacyclovir, famciclovir) shortens outbreaks and suppressive daily dosing reduces recurrences and transmission.
• Open communication, safe‑sex practices, and regular medical follow‑up enable a healthy, active life.

For personalized advice, always consult a healthcare professional. The information above reflects current guidance from reputable sources such as the CDC, Mayo Clinic, WHO, and the Cleveland Clinic.

```